Pure Global AI
ANVISA registration 80944340016Active

GLYCATED HEMOGLOBIN (HbA1C)

ANVISA Registration Number: 80944340016TRINITY BIOTECH DO BRASIL COMÉRCIO E IMPORTAÇÃO LTDA.TRINITY BIOTECHRisk Class II
Device names
Technical name
GLYCATED HEMOGLOBIN (HbA1C)
PT: HEMOGLOBINA GLICADA (HbA1C)
Commercial name
Tri-stat Liquid Controls Kit
Risk class
Class II
Registration details
Registration Number
80944340016
Process Number
25351655800201841
CNPJ
15648426000123
Company information
Manufacturer
TRINITY BIOTECH
Manufacturing Country
United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
Publication Date
Mar 25, 2019
Status
Active
Official value: VIGENTE
About this record

Access comprehensive regulatory information for GLYCATED HEMOGLOBIN (HbA1C) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80944340016 and manufactured by TRINITY BIOTECH. The registration is held by TRINITY BIOTECH DO BRASIL COMÉRCIO E IMPORTAÇÃO LTDA. with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.